Deepa Rajagopalan, M.D.

Deepa Rajagopalan is currently Chief Product and Strategy Officer at Viridian Therapeutics. She joined Viridian to lead New Product and Portfolio Development in 2021. Prior to joining Viridian, Deepa was VP of New Products at Intercept. In this role, Deepa led commercial planning, early-stage development, and corporate development for Intercept’s pipeline. Prior to that she held strategy and global marketing roles at Alexion. Previously, Deepa was a leader in the healthcare consulting practice at Bain & Company and built and led the biopharma commercial strategy practice at Science Group PLC. She previously trained as a surgical resident at the Cleveland Clinic Health System and at Western Pennsylvania Hospital. 

Deepa received an M.D. from University of Delhi and an M.B.A. from London Business School.